CAS: 3324-71-8; 1,3-Dimethylguanidine

该化合物是一种有机化合物,其特征为guanidine结构,其中两个甲基组群附在氮原子上;一种无色的黄色液体,其气味类似于氨,其色味很强;这种化合物溶于水和极地有机溶剂,其多种化学用途具有多种特性;二甲基谷氨基胺的特性明显高于氨基化合物,因其对甲基组的电温效应而明显高于氨基化合物;它经常被用作有机合成的试剂,特别是在生产药品和农用化学品时;此外,它在某些化学反应中起到催化剂的作用,包括聚合过程;安全考虑在处理二甲基谷碘时十分重要,因为它可能会刺激皮肤,眼睛和呼吸系统;应当使用适当的保护设备来尽量减少接触.

结构式图片

相似化合物

154476-57-0 216584-22-4 21770-81-0

MSDS等安全信息

    上下游产品

    CAS号4245-76-5 甲基硝基胍 | CAS号74-89-5 氨基甲烷 | CAS号506-68-3 溴化氰 | CAS号13830-58-5 N-METHYL-N′-NIT... | CAS号506-78-5 碘化氰 | CAS号2812-77-3 diethoxymethanimine | CAS号113-00-8 guanidine | CAS号74-88-4 碘甲烷 | CAS号506-77-4 氯化氰 | CAS号6972-05-0 N,N-二甲基硫脲

    合成工艺路线路线简述

      📜5-Brom-1,2-Dihydro-1-Methyl-2-Methylimino-Pyrimidin置于sodium Hydroxide体系中,化学反应生成1,3-二甲基胍
      参考文献:1303. Dimroth重排.第五部分.1-烷基-1,2-二氢-2-亚氨基嘧啶在水溶液中重排的机理
      标题:1303. Dimroth重排.第五部分.1-烷基-1,2-二氢-2-亚氨基嘧啶在水溶液中重排的机理
      摘要:
      Doi:10.1039/jr9650007071

      海关参考信息

      专利信息


      专利号:WO-9312076-A1
      优先权日:1991-12-13
      标题:Reagents for automated synthesis of peptide analogs
      发明人:WEBB THOMAS ROY
      权利人:CORVAS INT INC
      摘要:Reagents suitable for synthesis of peptide analogs using automated peptide synthesis and procedures for synthesis of peptide analogs are provided.

      专利号:US-6639059-B1
      优先权日:1999-03-24
      标 题 :Synthesis of [2.2.1]bicyclo nucleosides
      发明人:KOCHKINE ALEXEI; FENSHOLDT JEF; PFUNDHELLER HENRIK M
      权利人:EXIQON AS
      摘要:A synthesis of [2.2.1]bicyclo nucleosides which is shorter and provides higher overall yields proceeds via the key intermediate of the general formula III, wherein R4 and R5 are, for instance, sulfonates and R7 is, for instance, a halogen or an acetate. From compounds of the general formula II, such as 3-O-aryl-4-C-hydroxymethyl-1,2-O-isopropylidene-alpha-D-ribofuranose, intermediates of the general formula III are suitable for coupling with silylated nucleobases. Upon one-pot base-induced ring-closure and desulfonation of the formed [2.2.1]bicyclo nucleoside, a short route to each the LNA (Locked Nucleic Acid) derivatives of adenosine, cytosine, uridine, thymidine and guanidine is demonstrated. The use of the 5'-sulfonated ring-closed intermediate also allows for synthesis of 5'-amino- and thio-LNAs.

      专利号:US-6734291-B2
      优先权日:1999-03-24
      标题:Synthesis of [2.2.1]bicyclo nucleosides
      发明人:KOCHKINE ALEXEI; FENSHOLDT JEF; PFUNDHELLER HENRIK M
      权利人:EXIQON AS
      摘要:A synthesis of [2.2.1]bicyclo nucleosides which is shorter and provides higher overall yields proceeds via the key intermediate of the general formula III, wherein R4 and R5 are, for instance, sulfonates and R7 is, for instance, a halogen or an acetate. From compounds of the general formula II, such as 3-O-aryl-4-C-hydroxymethyl-1,2-O-isopropylidene-alpha-D-ribofuranose, intermediates of the general formula III are suitable for coupling with silylated nucleobases. Upon one-pot base-induced ring-closure and desulfonation of the formed [2.2.1]bicyclo nucleoside, a short route to each the LNA (Locked Nucleic Acid) derivatives of adenosine, cytosine, uridine, thymidine and guanidine is demonstrated. The use of the 5'-sulfonated ring-closed intermediate also allows for synthesis of 5'-amino- and thio-LNAs

      专利号:US-7173021-B2
      优先权日:2004-09-02
      标题:Synthesis of temozolomide esters as potent anticancer pro-drugs for topical and transdermal applications in treatments of cancers
      发明人:WANG YONGFENG; CONWAY BARBARA R; SUPPASANSATORN PANASSAYA
      权利人:TIANJIN NORTH PHARM SCI TECH C
      摘要:This invention relates to the use of temozolomide esters (4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxylate esters) Formula 1 as potent anticancer pro-drugs for treatment of cancers by topical and transdermal applications, and to a novel process for synthesis of temozolomide esters by a direct esterification of temozolomide acid (3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxylic acid) with a halogeno-aliphatic compound in presence of a base, or with an alcohol in presence of a dehydrate agent

      专利号:US-8334381-B2
      优先权日:2006-11-16
      标题 :Process for the preparation of intermediates useful in the synthesis of imatinib
      发明人:FALCHI ALESSANDRO; GRENDELE ENNIO; MOTTERLE RICCARDO; STIVANELLO MARIANO
      权利人:FALCHI ALESSANDRO; GRENDELE ENNIO; MOTTERLE RICCARDO; STIVANELLO MARIANO; ITALIANA SINT SPA
      摘要:It is the object of the present invention a process for the preparation of 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-benzenediamine and analogues thereof, intermediates useful for the synthesis of Imatinib, or 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide.

      专利号:US-5097089-A
      优先权日:1987-08-29
      标 题 :Synthesis of glycerol from formaldehyde
      发明人:GRACEY BENJAMIN P; HUDSON BARRY; WILLIAMS PETER S
      权利人:BP CHEM INT LTD
      摘要:This invention relates to a process for synthesis of glycerol from formaldehyde, wherein formaldehyde under substantially anhydrous condition is self-condensed in a catalytic step is dihydroxyacetone which is separated from the self-condensation catalyst and hydrogenated catalytically to glycerol. n The feature of the invention is to have less than 0.4% w/w of water in the self-condensation reaction mixture thereby improving the process to produce glycerol in commercially viable rates and yields.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      合成参考文献


      摘要:von Angerer, S., Science of Synthesis Knowledge Updates, (2011) 1, 190.
      参考文献:10.1208/s12249-014-0151-6
      摘要:Karthikeyan K, Vijayalakshmi E, Korrapati PS. Selective Interactions of Zein Microspheres with Different Class of Drugs: An In Vitro and In Silico Analysis. AAPS PharmSciTech. 2014 May 30;15(5):1172–80. doi: 10.1208/s12249-014-0151-6.
      参考文献:10.1016/0014-2999(93)90667-7
      摘要:Hasan K, Heesen B, Corbett JA, McDaniel ML, Chang K, Allison W, Wolffenbuttel BHR, Williamson JR, Tilton RG. Inhibition of nitric oxide formation by guanidines. European Journal of Pharmacology. 1993 Nov;249(1-2):101–6. doi: 10.1016/0014-2999(93)90667-7.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知